RVPH: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, RVPH has $23,559,636 in assets. $6,119,155 in debts. $22,190,231 in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	22,190,231	14,438,792	13,183,259	10,363,714
Prepaid clinical trial costs	819,721	0	81,742	104,447
Prepaid expenses and other current assets	549,684	664,685	247,927	346,964
Total current assets	23,559,636	15,103,477	13,512,928	10,815,125
Non-current prepaid clinical trial costs	0	819,721	819,721	819,721
Total assets	23,559,636	15,923,198	14,332,649	11,634,846

Us-gaap_shorttermborrowings	231,274	406,875	0	113,246
Accounts payable	2,085,268	3,009,074	5,431,806	4,968,688
Accrued clinical expenses	2,675,687	2,582,094	2,891,175	5,470,185
Accrued compensation	408,519	485,899	784,956	602,592
Other accrued liabilities	718,407	791,611	630,471	922,592
Total current liabilities	6,119,155	7,275,553	9,738,408	12,077,303
Warrant liabilities	-	0	44,506	16,690
Total liabilities	6,119,155	7,275,553	9,782,914	12,093,993
Common stock, par value of 0.0001 515,000,000 shares authorized 12,810,377 and 5,872,865 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively	12,348	11,655	9,618	6,800
Stockholders equity	204,762,072	192,773,942	185,310,390	176,293,553
Accumulated deficit	-187,333,939	-184,137,952	-180,770,273	-176,759,500
Total stockholders' equity	17,440,481	8,647,645	4,549,735	-459,147
Total liabilities and stockholders equity	23,559,636	15,923,198	14,332,649	11,634,846

Unit: Dollar. Numbers labeled with * are estimated quarterly values.